Medical Device News Magazine

Dr Yelena Tropsha New Chief Technology Officer at Contraline

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • Over the course of her career, Dr Yelena Tropsha has been involved in the development, approvals, and launches of 19 Class II and Class III medical devices in urology and gynecology.

Dr Yelena Tropsha brings to Contraline over 25 years of medical device experience, from front-end innovation to commercialization.

She served for 10 years with Coloplast as Vice President of Implantable Devices, Urology where she was responsible for R&D, Clinical, Medical and Regulatory Affairs. Dr. Tropsha also held Vice Presidential positions with leading medical device companies DYSIS Medical and Neuronetics and senior technical positions at Medtronic and Becton Dickinson.

Over the course of her career, Dr Yelena Tropsha has been involved in the development, approvals, and launches of 19 Class II and Class III medical devices in urology and gynecology. In addition to medical device development, her expertise is in materials science with emphasis on polymers and biomaterials. She is listed as an inventor on over 25 patents and 20 publications.

“Yelena joins our team at an exciting time ahead of our first-in-human clinical trial of ADAM™, the world’s first injectable hydrogel designed to provide long-lasting, non-permanent vas-occlusion for men,” said Kevin Eisenfrats, Co-Founder and Chief Executive Officer of Contraline.

“We are charting the path to bring a revolutionary reproductive medical device like ADAM™ to market. We are also beginning to expand the potential uses for our hydrogel platform. We will greatly benefit from Yelena’s experience leading numerous companies with innovative medical devices in urology and gynecology to successful regulatory and commercial outcomes.”

At Contraline, Dr. Tropsha will spearhead R&D, regulatory affairs, and market access. She will also lead efforts to expand use of Contraline’s proprietary hydrogel platform for new indications in reproductive health beyond vas-occlusion.

“I am excited and honored to be part of Contraline’s team, representing a new era in contraceptive technologies. Contraline’s work to develop a hydrogel for vas-occlusion draws from my areas of interest and expertise: medical device development, urology, and polymer science. The opportunity to drive the ADAM™ product from preclinical studies through commercialization will be a career highlight for me,” said Yelena Tropsha.

Dr. Tropsha holds a master’s degree in Chemistry and a PhD in Polymer Science from Moscow State University in Russia.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.